CN Patent

CN102453026A — C-芳基葡糖苷衍生物、制备方法及其应用

Assigned to Shanghai Allist Pharmaceuticals Inc · Expires 2012-05-16 · 14y expired

What this patent protects

本发明公开了一种C-芳基葡糖苷衍生物、制备方法及其应用。本发明所述衍生物是与肠或肾脏的葡萄糖再吸收有关的钠依赖性葡萄糖协同转运蛋白2(SGLT2)抑制剂，具有良好的尿糖排泄作用，从而可用作治疗糖尿病和相关疾病的治疗剂。

USPTO Abstract

本发明公开了一种C-芳基葡糖苷衍生物、制备方法及其应用。本发明所述衍生物是与肠或肾脏的葡萄糖再吸收有关的钠依赖性葡萄糖协同转运蛋白2(SGLT2)抑制剂，具有良好的尿糖排泄作用，从而可用作治疗糖尿病和相关疾病的治疗剂。

Drugs covered by this patent

Patent Metadata

Patent number
CN102453026A
Jurisdiction
CN
Classification
—
Expires
2012-05-16
Drug substance claim
No
Drug product claim
No
Assignee
Shanghai Allist Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.